Skip to main content
logo
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,040.50
-29.10 (-2.72%)
Aug 8, 2025, 3:30 PM IST

Aurobindo Pharma Revenue

In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B INR with 9.39% growth. Aurobindo Pharma had revenue of 83.82B in the quarter ending March 31, 2025, with 10.58% growth.

Revenue
317.24B
Revenue Growth
+9.39%
P/S Ratio
1.94
Revenue / Employee
12.31M
Employees
26,015
Market Cap
621.23B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025317.24B27.22B9.39%
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories96.52B
Cipla274.80B
Mankind Pharma129.10B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Fortis Healthcare77.86B
Alkem Laboratories129.65B
Revenue Rankings

Aurobindo Pharma News

More News